<DOC>
	<DOCNO>NCT02440971</DOCNO>
	<brief_summary>Up 60 % patient heart failure show abnormal pattern breathe ( sleep disorder breathing ( SDB ) ) night increase risk recurrent admission important prognostic implication . SDB however , treatable use non invasive breathe support device adaptive servo ventilation ( ASV ) device . The aim study observe investigate potential role ASV management heart failure . Patients agree participate study request use ASV ventilator device ( call AutoSet CS-A ) help SDB approximately 6 week . The device approximately size large shoe box , place side bed , tube mask . At night , mask place nose and/or mouth blow positive air pressure determine device constantly monitor patient breathe throughout night . During study , patient breathe pattern monitor non-invasively use ApneaLink device . A non-contact device know SleepMinder sit patient bedside locker another form monitoring sleep pattern . Study staff monitor patient give frequent support , also ask question regard experience equipment symptom may time . They follow regard study time follow-up requirement heart failure . This study conduct total 3 month .</brief_summary>
	<brief_title>Adaptive Servo Ventilation ( ASV ) Heart Failure</brief_title>
	<detailed_description>Sleep disorder breathing ( SDB ) common patient heart failure ( HF ) independent predictor morbidity mortality . Adaptive servo-ventilation ( ASV ) report effective treatment SDB HF show improve cardiac function patient HF coexistent SDB . ASV may also effective therapeutic option patient HF regardless presence severity SDB . The aim study investigate potential role ASV improve management ADHF acute hospital phase reduce complication vulnerable post discharge period . This observational study forty patient admit hospital ADHF . In clinical investigation , ApneaLinkTM Plus device measure patient respiratory nasal airflow , snore , blood oxygen saturation , pulse respiratory effort sleep . The research participant connect device inpatient hospitalisation soon stabilise oxygen . These recording aid diagnosis SDB clinical investigation . The S9 Autoset CS-A system evaluate determine whether ASV beneficial effect cardiac function patient ADHF . During in-patient run-in phase , patient tolerability ASV therapy assess tolerate well , patient continue therapy follow discharge 45 day . The SleepMinder sensor device monitor sleep breathing pattern participant sleep , , sleep apnoeas detect . Each patient monitor weight daily use Precision Personal Health Scales 90 day . Finally , questionnaire complete patient allows self-report HF symptom .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>Admitted hospital primary diagnosis ADHF Stable oxygen 24 hour Informed consent Age â‰¥ 18 year Age &lt; 18 year Pregnant woman , breastfeed mother Anyone capable give informed consent Contraindications positive airway pressure : Severe bullous lung disease Dehydration Cerebrospinal fluid leak Acute sinusitis otitis medium Epistaxis ( severe nose bleeds ) cause risk pulmonary aspiration Conditions predisposing risk vomit mask Impaired ability clear secretion Hypotension ( define systolic BP &lt; 100mmHg ) significant intravascular volume depletion Pneumothorax pneumomediastinum Recent cranial trauma surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Adaptive Servo Ventilation</keyword>
	<keyword>Acute decompensated heart failure</keyword>
	<keyword>SleepMinder</keyword>
	<keyword>ApneaLink Plus</keyword>
	<keyword>Sleep disorder breathing</keyword>
	<keyword>Natriuretic peptide</keyword>
</DOC>